identification of tax2 peptide as a new unpredicted anti-cancer agent TAX2 peptide - igf-1-peptide-reddit TAX2 peptide can be used to study angiogenesis and tumor cell interactions Identification of TAX2 Peptide as a Novel Anti-Cancer Agent

igf-1-peptide-reviews The identification of the TAX2 peptide as a new, unpredicted anti-cancer agent represents a significant stride in the ongoing exploration of novel therapeutic strategies作者：A Jeanne—Figure 1:TAX2 peptideimpedes tumor angiogenesis in a subcutaneous mouse ... (2015)Identification of TAX2 peptideas anew unpredicted anti-cancer agent.. This peptide, initially identified through research into tumor pathology, has demonstrated remarkable potential in combating cancer through its unique mechanism of action(PDF) Identification of TAX2 peptide as a new unpredicted .... The TAX2 peptide functions as a selective antagonist, specifically targeting the interaction between thrombospondin-1 (TSP-1) and its receptor, CD47. This interaction is crucial in the tumor microenvironment, and by disrupting it, TAX2 peptide exerts potent anti-cancer effects, primarily through its anti-angiogenic properties.

Understanding the Mechanism of TAX2 Peptide

The anti-cancer efficacy of TAX2 peptide is deeply rooted in its ability to modulate the tumor microenvironmentTAX-2 - Drug Targets, Indications, Patents. Tumors often rely on the formation of new blood vessels, a process known as angiogenesis, to sustain their growth and proliferationIdentification of TAX2 peptide as a new unpredicted anti-cancer agent[J]. Oncotarget, 2015, 6(20): 17981. *注: 文献方法仅供参考, InvivoChem并未独立验证这些 .... TAX2 peptide actively inhibits this process. It achieves this by promoting TSP-1 binding to CD36-containing complexes, which subsequently leads to the disruption of vascular endothelial growth factor receptor 2 (VEGFR2) activation. This disruption effectively starves the tumor of the necessary blood supply, thereby impairing its growth. Furthermore, TAX2 peptide acts as a modulator, reprogramming highly vascularized tumors into less angiogenic ones, significantly limiting their ability to spread and metastasize作者：A Jeanne·2017·被引用次数：39—Jeanne, A. et al.Identification of TAX2 peptide as a new unpredicted anti-cancer agent. Oncotarget 6, 17981–18000 (2015). Article PubMed PubMed .... The peptide's capacity to inhibit angiogenesis has been a key focus in studies, demonstrating its robust anti-angiostatic effectsJeanne, A., el al., "Identification of TAX2 peptide as a new unpredicted anti-cancer agent", Oncotarget, vol. 6, No. 20, pp. 17981-18000, May 22, 2015 ....

TAX2 Peptide and Tumor Angiogenesis

The relationship between TAX2 peptide and tumor angiogenesis is a central theme in its anti-cancer activity. Research has shown that TAX2 peptide impedes tumor angiogenesis in preclinical models, such as in subcutaneous mouse models. This impediment is critical because uncontrolled angiogenesis fuels tumor development. By targeting the TSP-1/CD47 interaction, TAX2 peptide effectively disrupts the signaling pathways that promote blood vessel formation within the tumorIdentification of TAX2 peptide as a new unpredicted anti-cancer agent. A Jeanne, E Sick, J Devy, N Floquet, N Belloy, L Theret, ... Oncotarget 6 (20), 17981 .... This targeted approach offers a distinct advantage over broader anti-angiogenic therapies, potentially leading to fewer off-target effects.Publications | Laboratoire de bioimagerie et pathologies | LBP The ability of TAX2 peptide to reprogram the tumor microenvironment from a pro-angiogenic state to an anti-angiogenic one highlights its sophisticated mode of action.Identification of TAX2 peptide as a new unpredicted anti-cancer agent. Oncotarget. 2015-07 | Journal article. DOI: 10.18632/oncotarget.4025. Show more detail.

Therapeutic Potential and Future Directions

The identification of TAX2 peptide as a potent anti-cancer agent opens avenues for new therapeutic strategies.TAX2 peptide (HY-P10388-50mg) at Hölzel-Diagnostika Its specific mechanism of action, targeting the critical TSP-1/CD47 interaction, suggests potential applications in various cancer typesThrombospondin-1 Mimetic Agonist Peptides Induce .... Studies have explored its potential in ovarian cancer therapy, aiming for a comprehensive molecular characterization of its mode of action. Beyond its direct anti-angiogenic effects, TAX2 peptide has also been investigated for its impact on platelet aggregation and interaction with collagen, suggesting broader implications in vascular health and potentially in preventing tumor cell interactions within the tumor microenvironmentTowards the Therapeutic Use of Thrombospondin 1/CD47 .... While the research is promising, further investigation is required to fully understand its therapeutic utility and to translate these findings into clinical applications for cancer treatment.Recherche française en oncopédiatrie The ongoing research into TAX2 peptide underscores the importance of exploring novel peptide-based agents in the fight against cancer.